Funds Stocks Activity Screener Pricing

Sign in Upgrade

Institutional ownership & 13F research, built on official SEC filings. Track what the smart money is buying and selling.

Research

Institutional Funds
Stocks & Ownership
Screener
Latest Activity

Product

Pricing
Sign In
Create Account
My Account

About

About FBInvestor
Data & Methodology
Disclaimer

© 2026 FBInvestor. Data sourced from SEC EDGAR Form 13F filings.

Not investment advice. For informational purposes only.

Halozyme Therapeutics Inc — Insider Transactions (Form 4) · FBInvestor

Stocks / Halozyme Therapeutics Inc

Institutional Ownership

Halozyme Therapeutics Inc

CUSIP 40637HAF6NOTE 1.000% 8/1HALOQ4 2025

Overview Short Owners Forecast Dividends Earnings Insider

No Form 4 insider transactions ingested yet

Insider (Form 4) filings for Halozyme Therapeutics Inc are fetched from SEC EDGAR on a rolling basis. Check back shortly.